Patient of the Month – July 2024: Tom Tiefert
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Tom Tiefert shares his story.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Tom Tiefert shares his story.
The Life Raft Group is proud to share our ASCO Educational Book Manuscript - “Leveraging Patient Engagement Through Collaboration for Improved Global Health Outcomes in Sarcoma”
Nutrition is important to keep in mind during any cancer treatment, but especially during a clinical trial.
GISTer Kandee Evans openly shares her experiences as a new clinical trial participant in the StrateGIST 1 trial sponsored by IDRx.
Discover the highlights & impact of The Life Raft Group in our 2023 Annual Report. https://bit.ly/LRG-AR2023
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Joy Knopp shares her story.
REGISTER The global GIST community converges, creating a supportive environment where individuals can connect with others who understand the challenges they face. Attendees gain access to a wealth of information [...]
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Rachel Wilborn shares her story.
Studies have shown that if you have GIST with mutations in KIT exons 11 and 17/18, ripretinib may be a better option for second-line treatment than the standard sunitinib.
Clinical trials are an essential part of medical research, aimed at introducing new procedures and treatments to the public.